Ciloa

Ciloa is an exosome-based R&D powerhouse that harnesses the potential of exosomes with its unique proprietary technology.

[Laura Miers @LauraMiers]

“The researchers also found evidence suggesting that SARS-CoV-2, the coronavirus that causes COVID-19, can induce hyperglycemia by disrupting fat cells’ production of adiponectin, a hormone that helps regulate blood sugar levels.” https://t.co/gRX6XanbYr

[Henne_Lab @HenneLab]

Fascinating new study on the influence of adipokine adiponectin on mouse lifespan & healthspan. Adiponectin-null mice show aging related defects in glucose & fat metabolism. Transgenic mice with elevated circulating adiponectin have increased healthspan.

https://t.co/zLJURrcWlM

[Diabetologia @DiabetologiaJnl]

Adiponectin treatment improves insulin resistance by regulating the expression of the mitochondrial-derived peptide MOTS-c and its response to exercise via APPL1/SIRT1/PGC-1α. #Diabetes #InsulinResistance https://t.co/zk0eDD3BxG

[bioRxiv @biorxivpreprint]

Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in mice. https://t.co/h9HbVxsDVF #bioRxiv

[Colin Hisey @ColinHisey]

Two oral presentations of some final @HEVI_NZ work done at #ISEV2022, now I can relax! Feeling motivated to get back in the lab, thanks again @IsevOrg and @OSUengineering for the support. Lyon has been a great venue.

[mel raz @melraz81]

If you’re interested on pregnancy, exosomes and gestational diabetes let’s meet at the poster session today at #ISEV2022! ✨🫧

[Tanina Arab @ArabTanina]

It was my great honor to present the data of our collaborative project with @Yiyao_Huang @LabWitwer this morning during Biomarkers of Neuronal Diseases #ISEV2022 session @JHPDA @JohnsHopkins

[Roger Olofsson Bagge @OlofssonBagge]

@janlotvall presents at #ISEV2022 the sky-rocketing success of the Journal of Extracellular Vesicles (#JEV) with an impact of 25.8

[Adityas Purnianto @AdityasPurnian1]

Representing @Dr_LauraV lab at #ISEV2022 to present my PhD work done in @TheFlorey investigating mitochondrial component and lipid peroxidation in EVs. Can these contents of EVs detect mitochondrial dysfunction and oxstress in Parkinson’s disease?

[FrenchSocEVs @French_Soc_EVs]

The new board has been voted #ISEV2022 @IsevComms

[Lorraine O'Driscoll @lodrisc1]

Congratulations everyone - you’ll have great fun!! #ISEV2022 #Lyon

[Finnish Society of Extracellular Vesicles @Fisev_society]

PS08.10 Petra Kangas from @NeuroPetGroup @LifeSciHelsinki: The effect of starting volume of cerebrospinal fluid for extracellular vesicle proteomics profile. #ISEV2022

[Marina Cretich @MarinaCretich]

Congratulations to the new board of directors 👏👏👏 @EditBuzas @BBussolati @BBussolati #MetkaLenassi @IsevComms @EVItaSociety #ISEV2022

[Ciloa @ciloabiotech]

@ciloabiotech team is pleased to welcome you at #Isev2022 booth 10, and share our lastest EVs innovations.

[Ciloa @ciloabiotech]

@ciloabiotech’s team will be pleased to present its last progress on extracellular vesicle (EV) editing and production. Come visit us at #ISEV2022 booth 10 from 25 to 29 May at the Lyon Convention Centre.

[Ciloa @ciloabiotech]

Hier, débat sur les levées de fonds ds les biotechs à Pérols. #Eurobiomed présenta l'expérience de 3 entrep. #Acobiom, #Ciloa, #Microphyt

[Norolanto Razafinimanana @norolanto]

#crowdfunding pour Biotech, c'est complexe car le retour sur investissement n'est pas de 2 ans mais de 10 ans! @PoleEurobiomed #LV_Biotech

[Pierre Bruynooghe @P_Bruynooghe]

Michek #Kaczorek (à d.) et Robert #Mamoun de #Ciloa (au c.) pdt la soirée levée de fonds au Fou du Sud

[Ciloa @ciloabiotech]

Ciloa est engagé depuis plusieurs mois dans un #vaccin sans #virus ni adjuvants contre #zika

[Ciloa @ciloabiotech]

Ciloa est engagé depuis plusieurs mois dans un #vaccin sans #virus ni adjuvants contre #Zika